Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China
· Delayed Price · Currency is CNY 20.15
-0.07 (-0.35%)
Feb 28, 2025, 2:45 PM CST
SHE:300255 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 27, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 18,390 | 11,957 | 5,036 | 7,472 | 5,693 | 5,086 | Upgrade
|
| Market Cap Growth | -2.47% | 137.41% | -32.60% | 31.26% | 11.92% | 33.01% | Upgrade
|
| Enterprise Value | 20,371 | 14,091 | 6,817 | 8,617 | 6,631 | 5,394 | Upgrade
|
| Last Close Price | 20.01 | 13.01 | 5.47 | 8.09 | 6.15 | 5.40 | Upgrade
|
| PE Ratio | - | - | 287.58 | 31.99 | 22.51 | 22.58 | Upgrade
|
| Forward PE | - | 12.44 | 12.44 | 12.44 | 12.44 | 12.44 | Upgrade
|
| PS Ratio | 14.64 | 8.48 | 2.16 | 2.52 | 2.41 | 2.46 | Upgrade
|
| PB Ratio | 10.11 | 6.64 | 1.65 | 2.43 | 2.00 | 1.87 | Upgrade
|
| P/TBV Ratio | 7.96 | 8.02 | 1.80 | 2.68 | 2.20 | 2.00 | Upgrade
|
| P/FCF Ratio | 129.23 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 39.01 | 354.53 | 1611.41 | 2602.11 | - | - | Upgrade
|
| EV/Sales Ratio | 19.31 | 9.99 | 2.92 | 2.90 | 2.81 | 2.60 | Upgrade
|
| EV/EBITDA Ratio | - | - | 41.33 | 22.68 | 15.64 | 15.09 | Upgrade
|
| EV/EBIT Ratio | - | - | 63.13 | 26.59 | 17.98 | 17.68 | Upgrade
|
| EV/FCF Ratio | 143.15 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.32 | 1.32 | 0.82 | 0.57 | 0.47 | 0.31 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 15.10 | 4.58 | 3.14 | 2.38 | Upgrade
|
| Debt / FCF Ratio | 16.46 | - | - | - | - | - | Upgrade
|
| Asset Turnover | 0.21 | 0.27 | 0.42 | 0.61 | 0.56 | 0.53 | Upgrade
|
| Inventory Turnover | 0.84 | 0.85 | 0.56 | 0.60 | 0.45 | 0.45 | Upgrade
|
| Quick Ratio | 0.31 | 0.29 | 0.72 | 0.52 | 0.67 | 0.80 | Upgrade
|
| Current Ratio | 1.13 | 1.18 | 2.18 | 1.97 | 2.12 | 2.13 | Upgrade
|
| Return on Equity (ROE) | -39.82% | -51.43% | 0.33% | 7.81% | 9.01% | 8.48% | Upgrade
|
| Return on Assets (ROA) | -11.64% | -13.46% | 1.20% | 4.15% | 5.41% | 4.90% | Upgrade
|
| Return on Capital (ROIC) | -12.76% | -14.74% | 1.30% | 4.50% | 5.94% | 5.39% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 2.54% | 9.38% | 11.67% | 11.08% | Upgrade
|
| Earnings Yield | -4.59% | -10.37% | 0.35% | 3.13% | 4.44% | 4.43% | Upgrade
|
| FCF Yield | 0.77% | -1.72% | -8.50% | -4.08% | -6.73% | -4.36% | Upgrade
|
| Dividend Yield | 0.00% | - | 0.09% | 0.32% | - | 0.24% | Upgrade
|
| Payout Ratio | 0.00% | - | 708.02% | 26.50% | 27.08% | 31.78% | Upgrade
|
| Buyback Yield / Dilution | 8.98% | -4.91% | 6.27% | 0.23% | 0.24% | -0.58% | Upgrade
|
| Total Shareholder Return | 8.98% | -4.91% | 6.37% | 0.55% | 0.24% | -0.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.